Comparison

GNE-149 European Partner

Item no. HY-145341-50mg
Manufacturer MedChem Express
CASRN 1953132-75-6
Amount 50 mg
Category
Type Inhibitors
Specific against other
Purity 99.66
Formula C28H33F4N3O
Citations [1]Jun Liang, et al. Discovery of GNE-149 as a Full Antagonist and Efficient Degrader of Estrogen Receptor alpha for ER+ Breast Cancer. ACS Med Chem Lett. 2020 May 26;11(6):1342-1347.
Smiles CC(C)(F)CN1[C@@](C2=C(C=C(C=C2F)OC3CN(C3)CCCF)F)([H])C4=C(C[C@H]1C)C5=CC=CC=C5N4
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Product Description
GNE-149 is an orally bioavailable full antagonist of estrogen receptor α (ERα; IC50=0.053 nM). GNE-149 is a selective estrogen receptor degrader (SERD). GNE-149 can be used for the research of breast cancer[1].
StorageTemperature
4°C (Powder, protect from light)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
503.57
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturers Target
Estrogen Receptor/ERR
Isoform
ERα
Pathway
Vitamin D Related/Nuclear Receptor
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close